For Cell And Gene Therapies, Expedited Designation And Complex Questions Improve FDA Meeting Chances

 
• By Sue Sutter
  
Complicated wires
The more complicated the product, the more likely a cell or gene therapy sponsor is to have its meeting request granted by the FDA. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies